Introduction
Two cases of hepatocellular carcinoma arising in renal transplant recipients have been recorded. One had renal failure due to chronic pyelonephritis and had evidence of severe fatty change with haemosiderin deposits in the liver at post mortem (Arbus and Hung, 1972) . The other had renal failure due to chronic glomerulonephritis and had a hepatitis B positive chronic active hepatitis with early cirrhosis (Pritzker, 1972 (Penn and Starzl, 1973) . However, this is unlikely to be the sole reason for the increased incidence of malignancy since the distribution in the type of malignancy is so different from that of the normal population and non-immunosuppressed mouse homograft recipients may develop malignant lymphomas (Myking, 1969) . Secondly, the transplanted tissue acts as a large mass of antigen stimulating the lymphoreticular system and, thirdly, it has been suggested that virus activation may be important. Ninety per cent of transplant recipients get clinical or serological evidence of herpes simplex virus infection and there is good evidence that the Epstein-Barr virus is involved in the induction of some lymphomas (Matas, Simmons and Najarian, 1975 
